Ethyne

Ethyne

SCHEMBL4180865

C#C.Cl.[MgH2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Ethyne. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyne SCHEMBL2432764 0.87
Ethyne SCHEMBL28783506 0.87
Ethyne SCHEMBL11118593 0.87
Ethyne SCHEMBL2196834 0.87
Ethyne SCHEMBL27737082 0.87
Ethyne SCHEMBL668732 0.87
Ethyne SCHEMBL1072332 0.75
Ethyne SCHEMBL11861627 0.75
Ethyne SCHEMBL7874434 0.75
Ethyne SCHEMBL4174371 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109517027-B Preparation method of danazol 江苏联环药业股份有限公司 2020-07-03 CN claimed
CN-102320927-B Synthesis method of 3-butyne-1-ol HAIMEN RUIYI MEDICAL TECHNOLOGY CO LTD 2013-10-02 CN claimed
CN-102320927-A Synthesis method of 3-butyne-1-ol HAIMEN RUIYI MEDICAL TECHNOLOGY CO LTD 2012-01-18 CN claimed
CN-119019211-A Method for synthesizing diacetylene benzene 珠海固瑞泰复合材料有限公司 2024-11-26 CN disclosed
CN-109517027-B Preparation method of danazol 江苏联环药业股份有限公司 2020-07-03 CN disclosed
CN-108059585-B Preparation method of 2-methyl-1-ethynyl-2-penten-1-ol 江苏扬农化工股份有限公司 2020-06-09 CN disclosed
CN-103242192-B The inhibitor of 11-beta-hydroxysteroid dehydrogenase 1 type enzyme ABBVIE INC. (US) 2016-05-04 CN disclosed
CN-102320927-B Synthesis method of 3-butyne-1-ol HAIMEN RUIYI MEDICAL TECHNOLOGY CO LTD 2013-10-02 CN disclosed
CN-103242192-A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme ABBVIE INC 2013-08-14 CN disclosed
CN-102320927-A Synthesis method of 3-butyne-1-ol HAIMEN RUIYI MEDICAL TECHNOLOGY CO LTD 2012-01-18 CN disclosed
CN-101786959-A Method for preparing chiral cylopropyl acetenyl tertiary alcohol compound SHANGHAI DESANO PHARMACEUTICAL 2010-07-28 CN disclosed
US-4189597-A PROSTAGLANDINS, BRONCHODILATORS AMERICAN CYANAMID COMPANY (US) 1980-02-19 US disclosed
US-4178456-A PROSTAGLANDINS AMERICAN CYANAMID COMPANY (US) 1979-12-11 US disclosed
US-4172839-A PROSTAGLANDINS AMERICAN CYANAMID COMPANY (US) 1979-10-30 US disclosed
US-4170597-A 1-Hydroxymethyl-1-oxo-prostane derivatives of the E2 series AMERICAN CYANAMID COMPANY (US) 1979-10-09 US disclosed
US-4165331-A PROSTAGLANDINS/AND DERIVATIVES AMERICAN CYANAMID COMPANY (US) 1979-08-21 US disclosed
EP-0002590-A1 Novel prostaglandin compounds, processes for the preparation thereof and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-06-27 EP disclosed
US-4154959-A 11-(2-Hydroxyethylthio)prostenoic acid E series derivatives AMERICAN CYANAMID COMPANY (US) 1979-05-15 US disclosed
US-4154954-A BRONCHODILATOR AGENTS; ANTIINFLAMMATORY AGENTS AMERICAN CYANAMID COMPANY (US) 1979-05-15 US disclosed
US-4085272-A BRONCHODILATORS, INFLAMMATORY MEDEATOR RELEASE INHIBITORS AMERICAN CYANAMID COMPANY (US) 1978-04-18 US disclosed